Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
(FY)Feb 1, 2025 | (Q4)Feb 1, 2025 | (Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -26.78%134M | -26.78%134M | -8.42%174M | 13.24%231M | -20.28%228M | 19.61%183M | 19.61%183M | -2.06%190M | -8.11%204M | -55.73%286M |
-Cash and cash equivalents | -26.78%134M | -26.78%134M | -8.42%174M | 13.24%231M | -20.28%228M | 19.61%183M | 19.61%183M | -2.06%190M | -8.11%204M | -55.73%286M |
Receivables | -4.79%159M | -4.79%159M | ---- | ---- | ---- | -20.48%167M | -20.48%167M | ---- | ---- | ---- |
-Taxes receivable | -60.00%4M | -60.00%4M | ---- | ---- | ---- | -62.96%10M | -62.96%10M | ---- | ---- | ---- |
-Other receivables | -1.27%155M | -1.27%155M | ---- | ---- | ---- | -14.21%157M | -14.21%157M | ---- | ---- | ---- |
Inventory | 2.26%2.95B | 2.26%2.95B | -3.30%4.1B | -9.30%3.15B | -12.56%3.08B | -9.69%2.88B | -9.69%2.88B | -13.03%4.24B | -13.88%3.47B | -5.62%3.53B |
Prepaid assets | -16.27%139M | -16.27%139M | ---- | ---- | ---- | -2.35%166M | -2.35%166M | ---- | ---- | ---- |
Other current assets | -21.43%11M | -21.43%11M | 18.21%344M | 11.82%331M | -0.58%345M | 0.00%14M | 0.00%14M | -20.49%291M | -20.86%296M | -8.92%347M |
Total current assets | -0.65%3.39B | -0.65%3.39B | -2.18%4.62B | -6.57%3.71B | -12.09%3.66B | -8.73%3.41B | -8.73%3.41B | -13.14%4.72B | -14.17%3.97B | -12.68%4.16B |
Non current assets | ||||||||||
Net PPE | -5.17%9.69B | -5.17%9.69B | -3.68%9.97B | -4.11%10.01B | -0.09%10.16B | -0.11%10.22B | -0.11%10.22B | -0.79%10.35B | -0.82%10.44B | 1.57%10.17B |
-Gross PPE | -2.31%17.03B | -2.31%17.03B | -3.68%9.97B | -4.11%10.01B | -0.09%10.16B | -0.45%17.43B | -0.45%17.43B | -0.79%10.35B | -0.82%10.44B | 1.57%10.17B |
-Accumulated depreciation | -1.75%-7.34B | -1.75%-7.34B | ---- | ---- | ---- | 0.92%-7.21B | 0.92%-7.21B | ---- | ---- | ---- |
Non current accounts receivable | 41.50%283M | 41.50%283M | ---- | ---- | ---- | 2.56%200M | 2.56%200M | ---- | ---- | ---- |
Non current deferred assets | 18.75%38M | 18.75%38M | ---- | ---- | ---- | -30.43%32M | -30.43%32M | ---- | ---- | ---- |
Other non current assets | 7.43%159M | 7.43%159M | 18.02%465M | 19.90%458M | 21.05%460M | 7.25%148M | 7.25%148M | 7.95%394M | -18.55%382M | -20.17%380M |
Total non current assets | -4.04%10.17B | -4.04%10.17B | -2.88%10.44B | -3.26%10.47B | 0.67%10.62B | -0.09%10.6B | -0.09%10.6B | -0.49%10.75B | -1.57%10.82B | 0.58%10.55B |
Total assets | -3.21%13.56B | -3.21%13.56B | -2.67%15.05B | -4.15%14.18B | -2.94%14.28B | -2.34%14.01B | -2.34%14.01B | -4.72%15.47B | -5.31%14.79B | -3.56%14.71B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 3.07%1.38B | 3.07%1.38B | -2.35%1.87B | -4.29%1.32B | -6.87%1.22B | -12.45%1.34B | -12.45%1.34B | -4.77%1.92B | -8.08%1.38B | -21.98%1.31B |
-accounts payable | -8.11%1.04B | -8.11%1.04B | -2.35%1.87B | -4.29%1.32B | -6.87%1.22B | -14.74%1.13B | -14.74%1.13B | -4.77%1.92B | -8.08%1.38B | -21.98%1.31B |
-Total tax payable | 65.84%335M | 65.84%335M | ---- | ---- | ---- | 3.06%202M | 3.06%202M | ---- | ---- | ---- |
Current accrued expenses | -7.74%620M | -7.74%620M | -5.97%1.25B | -4.90%1.19B | 8.68%1.27B | 0.60%672M | 0.60%672M | -7.80%1.32B | -12.62%1.25B | -11.55%1.16B |
Current debt and capital lease obligation | 198.19%826M | 198.19%826M | 39.50%1.28B | 10.38%936M | -51.11%528M | -50.97%277M | -50.97%277M | -11.78%914M | 89.71%848M | 170.68%1.08B |
-Current debt | 598.91%643M | 598.91%643M | 49.73%1.1B | 13.71%763M | -59.47%355M | -74.44%92M | -74.44%92M | -11.54%736M | 176.13%671M | 434.15%876M |
-Current capital lease obligation | -1.08%183M | -1.08%183M | -2.81%173M | -2.26%173M | -15.20%173M | -9.76%185M | -9.76%185M | -12.75%178M | -13.24%177M | -13.19%204M |
Current deferred liabilities | -5.81%308M | -5.81%308M | ---- | ---- | ---- | -8.15%327M | -8.15%327M | ---- | ---- | ---- |
Current liabilities | 19.87%3.13B | 19.87%3.13B | 5.70%4.39B | -0.92%3.44B | -15.22%3.01B | -16.15%2.61B | -16.15%2.61B | -7.36%4.16B | 2.97%3.47B | 4.71%3.55B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -10.79%6.33B | -10.79%6.33B | -8.78%6.51B | -8.43%6.54B | 1.30%7.07B | 1.40%7.1B | 1.40%7.1B | -0.01%7.13B | -0.01%7.14B | 2.60%6.98B |
-Long term debt | -28.33%1.17B | -28.33%1.17B | -28.33%1.17B | -28.34%1.17B | 0.06%1.64B | 0.06%1.64B | 0.06%1.64B | -6.24%1.64B | -6.30%1.64B | -6.24%1.64B |
-Long term capital lease obligation | -5.53%5.16B | -5.53%5.16B | -2.95%5.33B | -2.51%5.37B | 1.68%5.43B | 1.81%5.46B | 1.81%5.46B | 2.01%5.49B | 2.02%5.51B | 5.65%5.34B |
Non current deferred liabilities | -73.83%28M | -73.83%28M | -27.10%78M | -21.49%95M | -27.13%94M | -17.05%107M | -17.05%107M | -35.15%107M | -37.63%121M | -38.28%129M |
Other non current liabilities | -11.07%265M | -11.07%265M | -14.95%273M | -15.12%275M | -12.27%286M | -11.57%298M | -11.57%298M | -9.32%321M | -12.43%324M | -16.41%326M |
Total non current liabilities | -11.70%6.63B | -11.70%6.63B | -9.30%6.86B | -8.92%6.91B | 0.22%7.45B | 0.50%7.5B | 0.50%7.5B | -1.20%7.56B | -1.56%7.59B | 0.45%7.44B |
Total liabilities | -3.55%9.76B | -3.55%9.76B | -3.98%11.25B | -6.41%10.35B | -4.78%10.47B | -4.40%10.12B | -4.40%10.12B | -3.48%11.72B | -0.18%11.06B | 1.79%10.99B |
Shareholders'equity | ||||||||||
Share capital | -50.00%1M | -50.00%1M | 0.00%2M | 0.00%2M | 0.00%2M | -50.00%2M | -50.00%2M | -50.00%2M | -50.00%2M | -50.00%2M |
-common stock | -50.00%1M | -50.00%1M | 0.00%2M | 0.00%2M | 0.00%2M | -50.00%2M | -50.00%2M | -50.00%2M | -50.00%2M | -50.00%2M |
Retained earnings | -65.64%1.01B | -65.64%1.01B | 0.89%2.83B | 2.18%2.86B | 1.89%2.85B | -79.04%2.93B | -79.04%2.93B | -80.43%2.8B | -80.40%2.8B | -80.31%2.8B |
Paid-in capital | 0.91%3.56B | 0.91%3.56B | 1.14%3.55B | 1.26%3.55B | 1.43%3.54B | 1.41%3.53B | 1.41%3.53B | 5.88%3.51B | 2.82%3.5B | 2.77%3.49B |
Less: Treasury stock | -70.17%767M | -70.17%767M | 0.47%2.58B | 0.39%2.58B | 0.39%2.58B | -81.25%2.57B | -81.25%2.57B | -81.05%2.57B | -80.47%2.57B | -80.46%2.57B |
Total stockholders'equity | -2.34%3.8B | -2.34%3.8B | 1.41%3.8B | 2.54%3.83B | 2.50%3.81B | 3.45%3.89B | 3.45%3.89B | -8.42%3.75B | -17.80%3.74B | -16.52%3.72B |
Total equity | -2.34%3.8B | -2.34%3.8B | 1.41%3.8B | 2.54%3.83B | 2.50%3.81B | 3.45%3.89B | 3.45%3.89B | -8.42%3.75B | -17.80%3.74B | -16.52%3.72B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |